Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Sarclisa Market Report 2025

Sarclisa Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Formulation (Injectable Solution, Lyophilized Powder for Injection), By Clinical Indication (Relapsed Or Refractory Multiple Myeloma, Newly Diagnosed Multiple Myeloma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies)

Sarclisa Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Sarclisa Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Sarclisa Market Definition

Sarclisa is a monoclonal antibody used in the treatment of certain cancers, specifically multiple myeloma, a type of blood cancer. It works by targeting and binding to a protein called CD38, which is found on the surface of multiple myeloma cells. By binding to CD38, sarclisa helps the immune system recognize and destroy these cancerous cells. It is typically used in combination with other cancer therapies to improve treatment outcomes.

The main types of sarclisa formulations are injectable solution and lyophilized powder for injection. Relapsed or refractory multiple myeloma is a stage of multiple myeloma where the disease returns after initial treatment or no longer responds to therapy. It is used for relapsed or refractory multiple myeloma and newly diagnosed multiple myeloma and is distributed through both hospital and retail pharmacies.

Sarclisa Market Segmentation

The sarclisa market covered in this report is segmented –

1) By Formulation: Injectable Solution; Lyophilized Powder for Injection

2) By Clinical Indication: Relapsed Or Refractory Multiple Myeloma; Newly Diagnosed Multiple Myeloma

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies

Sarclisa Market Size and growth rate 2025 to 2029: Graph

Sarclisa Market Size 2025 And Growth Rate

The sarclisa market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to significant investments in oncology research, improvements in healthcare infrastructure, increasing aging population, government funding and reimbursement policies for cancer treatments, and expanding clinical trial programs.

Sarclisa Market Growth Forecast

The sarclisa market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growth of personalized medicine, shift toward immunotherapies, increasing prevalence of autoimmune diseases, growing focus on long-term remission, and awareness of hematological malignancies. Major trends in the forecast period include shift towards more targeted therapies, launch of biosimilars, advancements in molecular diagnostics, technological advancements in cancer diagnosis, and innovation in targeted cancer therapies.

Book your 30 minutes free consultation with our research experts

Contact Us

Sarclisa Market Driver: Rising Cancer Prevalence Drives Growth In The Sarclisa Market

The increasing prevalence of cancer is expected to propel the growth of the sarclisa market going forward. Cancer is a group of diseases characterized by uncontrolled cell growth and division, which can invade surrounding tissues and spread to other parts of the body, often forming tumors or metastases, and can affect various organs or systems. The increasing prevalence of cancer can be attributed to factors such as an aging population, lifestyle choices, environmental exposures, genetic predispositions, and improved detection methods leading to better diagnosis. Sarclisa is essential for treating cancer, particularly multiple myeloma, as it targets and eliminates cancerous plasma cells, bolstering the immune system's capacity to combat the disease and enhancing treatment effectiveness. For instance, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that 2022 saw approximately 20 million new cancer cases and 9.7 million cancer-related deaths globally. Lung cancer was the most prevalent, accounting for 2.5 million new cases (12.4% of the total), followed by female breast cancer with 2.3 million cases (11.6%) and colorectal cancer with 1.9 million cases (9.6%). By 2050, new cancer cases are projected to exceed 35 million, representing a 77% increase from 2022. Therefore, the increasing prevalence of cancer is driving the growth of the sarclisa market.

Sarclisa Market Driver: Growth Of The Geriatric Population To Drive Market

The growing geriatric population is expected to propel the growth of the sarclisa market going forward. The geriatric population refers to older adults, typically those aged 65 and above, who often experience distinct health, social, and economic challenges as they age. The geriatric population is rising due to factors such as longer life expectancy, advances in healthcare, and declining birth rates, which collectively contribute to an aging global population. Sarclisa is crucial for the geriatric population as it provides an effective treatment option for multiple myeloma, especially for older adults who may not qualify for intensive therapies such as autologous stem cell transplants. For instance, in October 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, it is anticipated that one in six people worldwide would be 60 years of age or older by 2030. By 2030, there will likely be 1.4 billion people over 60, up from 1 billion in 2020. By 2050, this group is predicted to have doubled in size from its current size to 2.1 billion. Therefore, the growing geriatric population will drive the growth of the sarclisa market.

Global Sarclisa Market Major Players

Major companies operating in the sarclisa market are Sanofi S.A.

Global Sarclisa Market Trend: Regulatory Approvals Drive Growth In The Sarclisa Market For Newly Diagnosed Multiple Myeloma

The key trend in the sarclisa market is securing drug approvals from regulatory authorities to treat adult patients with newly diagnosed multiple myeloma. Drug approval involves the evaluation and authorization of a new drug for sale and use, ensuring its safety, efficacy, and quality through rigorous clinical trial data assessment. For instance, in September 2024, Sanofi SA, a France-based pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved sarclisa (isatuximab) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) as a first-line treatment option for adult patients with newly diagnosed multiple myeloma (NDMM) who are ineligible for autologous stem cell transplant (ASCT). This approval follows the positive results of the IMROZ phase 3 study, which indicated that sarclisa, when combined with VRd, significantly reduced the risk of disease progression or death by 40% compared to VRd alone. This marks Sarclisa's third indication and underscores Sanofi's commitment to addressing a critical need in the treatment of multiple myeloma.

Regional Analysis For The Global Sarclisa Market

North America was the largest region in the sarclisa market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarclisa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sarclisa market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Sarclisa Market?

The sarclisa market consists of sales of chemotherapy agents, immunotherapy drugs, biosimilars, and diagnostic kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. 

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Sarclisa Industry?

The sarclisa market research report is one of a series of new reports from The Business Research Company that provides sarclisa market statistics, including sarclisa industry global market size, regional shares, competitors with a sarclisa market share, detailed sarclisa market segments, market trends and opportunities, and any further data you may need to thrive in the sarclisa industry. This sarclisa market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Sarclisa Market Characteristics

    3. Sarclisa Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Sarclisa Market Trends And Strategies

    5. Sarclisa Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Sarclisa Growth Analysis And Strategic Analysis Framework

    6.1. Global Sarclisa PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Sarclisa Market Growth Rate Analysis

    6.4. Global Sarclisa Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Sarclisa Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Sarclisa Total Addressable Market (TAM)

    7. Global Sarclisa Pricing Analysis & Forecasts

    8. Sarclisa Market Segmentation

    8.1. Global Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Injectable Solution

    Lyophilized Powder for Injection

    8.2. Global Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Relapsed Or Refractory Multiple Myeloma

    Newly Diagnosed Multiple Myeloma

    8.3. Global Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospital Pharmacies

    Retail Pharmacies

    9. Global Sarclisa Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Sarclisa Market Regional And Country Analysis

    10.1. Global Sarclisa Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Sarclisa Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Sarclisa Market

    11.1. Asia-Pacific Sarclisa Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Sarclisa Market

    12.1. China Sarclisa Market Overview

    12.2. China Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Sarclisa Market

    13.1. India Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Sarclisa Market

    14.1. Japan Sarclisa Market Overview

    14.2. Japan Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Sarclisa Market

    15.1. Australia Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Sarclisa Market

    16.1. South Korea Sarclisa Market Overview

    16.2. South Korea Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Sarclisa Market

    17.1. Western Europe Sarclisa Market Overview

    17.2. Western Europe Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Sarclisa Market

    18.1. UK Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Sarclisa Market

    19.1. Germany Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Sarclisa Market

    20.1. France Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Sarclisa Market

    21.1. Eastern Europe Sarclisa Market Overview

    21.2. Eastern Europe Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Sarclisa Market

    22.1. North America Sarclisa Market Overview

    22.2. North America Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Sarclisa Market

    23.1. USA Sarclisa Market Overview

    23.2. USA Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Sarclisa Market

    24.1. Canada Sarclisa Market Overview

    24.2. Canada Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Sarclisa Market

    25.1. South America Sarclisa Market Overview

    25.2. South America Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Sarclisa Market

    26.1. Middle East Sarclisa Market Overview

    26.2. Middle East Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Sarclisa Market

    27.1. Africa Sarclisa Market Overview

    27.2. Africa Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Sarclisa Market Competitive Landscape And Company Profiles

    28.1. Sarclisa Market Competitive Landscape

    28.2. Sarclisa Market Company Profiles

    28.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Sarclisa Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Sarclisa Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Sarclisa Market

    32. Recent Developments In The Sarclisa Market

    33. Sarclisa Market High Potential Countries, Segments and Strategies

    33.1 Sarclisa Market In 2029 - Countries Offering Most New Opportunities

    33.2 Sarclisa Market In 2029 - Segments Offering Most New Opportunities

    33.3 Sarclisa Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Sarclisa Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Sarclisa Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Sanofi S.A. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Sarclisa Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Sarclisa Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Sarclisa Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Sarclisa Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Sarclisa Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Sanofi S.A. Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the high potency apis market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the covid-19 current therapy market research report 2022 with industry size, share, segments and market growth

Read More

Microbiome Therapeutics Global Market Report 2022 – By Product (Probiotics, Prebiotics, Symbiotics, and Other Products), By Application (Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis, and Other Applications), By Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies, and E-commerce Stores) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Neurodegenerative Disorder Therapeutics Global Market Report 2025 – By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Antisense & RNAi Therapeutics Global Market Report 2025 – By Technology (RNA Interference, Antisense RNA), By Route of Administration (Intravenous Injections, Intra-dermal Injections, Other Delivery Methods), By Indication (Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Commercial Internal Combustion Engines Global Market Report 2025 – By Type (Petroleum, Natural Gas), By Power Output (100-300 kW, 300-500 kW, 0.5-1 MW, 1-5 MW, 5-15 MW, 15-25 MW, 25 MW And Above), By Application (Marine, Automotive, Aircraft, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Natural Refrigerants Global Market Report 2025 – By Type (Ammonia (R-717), Carbon Dioxide (R-74,, Hydrocarbons, Other Types), By Application (Refrigerators, Air Conditioning Systems, Other Applications), By End-Use Industry (Industrial, Commercial, Domestic) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Automotive Active Health Monitoring System Global Market Report 2025 – By Component (Sensors, Other Components), By Location (Driver Seat, Dashboard), By Deployment (On-Premise, Cloud-Based), By Vehicle (Passenger Vehicle, Commercial Vehicle), By Application (Pulse, Blood Sugar Level, Blood Pressure, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Alpha Mannosidosis Market 2022 - By Therapy Type (Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT)), By Indication (Type I, Type II, Type III), By End User (Hospital, Specialty Clinics), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Human Microbiome Therapeutics Market - By Disease (Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers), By Sequencing Technology Type (Targeted Gene, RNA, Whole-Genome Shotgun (WGS)) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the Sarclisa market?

Sarclisa is a monoclonal antibody used in the treatment of certain cancers, specifically multiple myeloma, a type of blood cancer. It works by targeting and binding to a protein called CD38, which is found on the surface of multiple myeloma cells. By binding to CD38, sarclisa helps the immune system recognize and destroy these cancerous cells. It is typically used in combination with other cancer therapies to improve treatment outcomes. For further insights on the Sarclisa market, request a sample here

How will the Sarclisa market drivers and restraints affect the market dynamics? What forces will shape the Sarclisa industry going forward?

The Sarclisa market major growth driver - Rising Cancer Prevalence Drives Growth In The Sarclisa Market. For further insights on the Sarclisa market, request a sample here

What is the forecast market size or the forecast market value of the Sarclisa market?

The Sarclisa market size has grown strongly in recent years. The sarclisa market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to significant investments in oncology research, improvements in healthcare infrastructure, increasing aging population, government funding and reimbursement policies for cancer treatments, and expanding clinical trial programs. The sarclisa market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growth of personalized medicine, shift toward immunotherapies, increasing prevalence of autoimmune diseases, growing focus on long-term remission, and awareness of hematological malignancies. Major trends in the forecast period include shift towards more targeted therapies, launch of biosimilars, advancements in molecular diagnostics, technological advancements in cancer diagnosis, and innovation in targeted cancer therapies. For further insights on the Sarclisa market, request a sample here

How is the Sarclisa market segmented?

The sarclisa market covered in this report is segmented –
1) By Formulation: Injectable Solution; Lyophilized Powder for Injection
2) By Clinical Indication: Relapsed Or Refractory Multiple Myeloma; Newly Diagnosed Multiple Myeloma
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies For further insights on the Sarclisa market, request a sample here

Which region has the largest share of the Sarclisa market? What are the other regions covered in the report?

North America was the largest region in the sarclisa market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarclisa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Sarclisa market, request a sample here.

Who are the major players in the Sarclisa market?

Major companies operating in the sarclisa market are Sanofi S.A. . For further insights on the Sarclisa market, request a sample here.

What are the key trends in the Sarclisa market?

Major trends in the Sarclisa market include Regulatory Approvals Drive Growth In The Sarclisa Market For Newly Diagnosed Multiple Myeloma. For further insights on the Sarclisa market, request a sample here.

What are the major opportunities in the Sarclisa market? What are the strategies for the Sarclisa market?

For detailed insights on the major opportunities and strategies in the Sarclisa market, request a sample here.

How does the Sarclisa market relate to the overall economy and other similar markets?

For detailed insights on Sarclisa's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Sarclisa industry?

For detailed insights on the mergers and acquisitions in the Sarclisa industry, request a sample here.

What are the key dynamics influencing the Sarclisa market growth? SWOT analysis of the Sarclisa market.

For detailed insights on the key dynamics influencing the Sarclisa market growth and SWOT analysis of the Sarclisa industry, request a sample here.